Showing results (421-430 of 987) with videos related to
Sort By:
Pageof 99
Angewandte Chemie (International Ed. in English)|November 25, 2025
Solvation-Competing Nitrile Polymer Gel Electrolyte for High-Voltage Quasi Solid State Lithium Metal BatteriesChen Dai, Fangzheng Liu, Yian Wang, et al.Nature Communications|March 4, 2022
Optical sensors for operando stress monitoring in lithium-based batteries containing solid-state or liquid electrolytesLaura Albero Blanquer, Florencia Marchini, Jan Roman Seitz, et al.Behavioural Neurology|February 4, 2014
Neuropsychological investigation of anterior and posterior cortical function in early-stage probable Alzheimer's diseaseP Broks, C Lines, L Atchison, et al.Human Psychopharmacology|November 6, 2008
Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjectsJulia Boyle, Dennis Wolford, Cynthia Gargano, et al.Journal of Cancer Survivorship : Research and Practice|September 19, 2020
Associations between shared care and patient experiences among older cancer survivorsMichael T Halpern, Julia Cohen, Lisa M Lines, et al.Animals : an Open Access Journal From MDPI|April 5, 2018
The Use of a Mechanical Non-Penetrating Captive Bolt Device for the Euthanasia of Neonate LambsAndrew Grist, Jeff A Lines, Toby G Knowles, et al.Endocrine-Related Cancer|June 27, 2020
Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs)Simona Grozinsky-Glasberg, Kate E Lines, Shani Avniel-Polak, et al.Journal of Geriatric Oncology|July 1, 2023
Associations between healthcare costs and care experiences among older adults with and without cancerBenjamin T Allaire, Diana Zabala, Lisa M Lines, et al.Sleep Medicine|December 18, 2022
Comparison of polysomnography in people with Alzheimer's disease and insomnia versus non-demented elderly people with insomniaPeining Tao, Vladimir Svetnik, Donald L Bliwise, et al.The International Journal of Neuropsychopharmacology|March 22, 2012
Lack of efficacy of L-759274, a novel neurokinin 1 (substance P) receptor antagonist, for the treatment of generalized anxiety disorderDavid Michelson, Richard Hargreaves, Robert Alexander, et al.Pageof 99